NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Annual report FY2026 PAR DRUGS AND CHEMICALS LIMITED - ANNUAL REPORT FY2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: ₹10,365.56 crore (FY2024-25: ₹10,097.3 | 2026-09-03 |
| Quarterly results · Q1 FY27 PAR DRUGS AND CHEMICALS LIMITED – QUARTERLY SUMMARY HEADLINE NUMBERS • Revenue from operations (Q1 FY2026-27): Rs 3,128.05 lakhs (up 20.1% YoY from | 2026-08-08 |
| Quarterly results · Q4 FY26 PAR DRUGS AND CHEMICALS LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Board Meeting Date: 14 May 2026 • Financial Year Covered: Year ended 31 March | 2026-05-14 |
| Quarterly results · Q3 FY26 PAR DRUGS AND CHEMICALS LIMITED – FINANCIAL SUMMARY Q3 FY2025-26 (9 Months Ended 31 December 2025) --- HEADLINE NUMBERS • Revenue from Operations ( | 2026-02-10 |
| Quarterly results · Q2 FY26 PAR DRUGS AND CHEMICALS LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 FY2025-26 (Quarter ended 30-Sept-2025): Revenue from operations Rs 2,865.8 | 2025-11-13 |
| Annual report FY2025 PAR DRUGS AND CHEMICALS LIMITED – ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Total Revenue (Standalone FY25): ₹10,312.38 lakh vs ₹9,588.27 lak | 2025-09-04 |
| Quarterly results · Q1 FY26 PAR DRUGS AND CHEMICALS LIMITED – Q1 FY2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations (Q1 FY26): Rs 2,604.64 lakhs, up 15.2% YoY from Rs | 2025-08-07 |
| Quarterly results | 2025-02-14 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Par Drugs And Chemicals Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.